All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits (vol 128, pg 638, 2022)Huai-liang Wu,Zi-yin Luo,Zong-lin He,Yue Gong,Miao Mo,Wai-kit Ming,Guang-yu LiuBRITISH JOURNAL OF CANCER(2023)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要